KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	64,009	94,499	86,288	104,097	97,646	101,826
Market Cap Growth	-26.85%	9.52%	-17.11%	6.61%	-4.11%	-7.83%
Enterprise Value	70,297	106,074	103,362	105,733	99,919	92,413
Last Close Price	1114.00	1645.00	1449.70	1686.23	1541.68	1559.85

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	29.46	27.41	9.50	19.56	20.68	25.90
Forward PE	40.81	20.76	20.70	17.98	18.11	30.61
PS Ratio	0.51	0.75	0.66	0.87	0.86	0.97
PB Ratio	0.46	0.66	0.63	0.80	0.78	0.82
P/TBV Ratio	0.47	0.68	0.66	0.83	0.81	0.84
P/FCF Ratio	25.43	37.54	-	-	-	26.10
P/OCF Ratio	10.03	14.81	24.61	67.20	48.63	16.05
PEG Ratio	-	9.56	9.56	9.56	9.56	9.56

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.56	0.84	0.80	0.89	0.88	0.88
EV/EBITDA Ratio	10.30	12.98	6.03	10.27	11.15	10.60
EV/EBIT Ratio	32.70	30.23	8.24	17.61	19.51	18.47
EV/FCF Ratio	27.93	42.14	-	-	-	23.68

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.17	0.17	0.21	0.16	0.17	0.17
Debt / EBITDA Ratio	3.43	2.91	1.66	2.03	2.37	2.48
Debt / FCF Ratio	-	9.45	-	-	-	5.54
Net Debt / Equity Ratio	0.05	0.06	0.09	0.05	0.02	-0.05
Net Debt / EBITDA Ratio	0.93	1.07	0.70	0.68	0.21	-0.67
Net Debt / FCF Ratio	-	3.46	-5.44	-1.65	-0.44	-1.50
Asset Turnover	0.66	0.65	0.70	0.68	0.65	0.62
Inventory Turnover	1.11	1.12	1.18	1.34	1.40	1.39
Quick Ratio	2.29	2.12	1.82	1.36	1.91	2.15
Current Ratio	5.18	4.60	3.88	2.62	3.40	3.62
Return on Equity (ROE)	1.57%	2.47%	6.80%	4.15%	3.78%	3.16%
Return on Assets (ROA)	0.69%	1.13%	4.22%	2.12%	1.84%	1.85%
Return on Invested Capital (ROIC)	1.06%	1.82%	6.24%	3.44%	2.85%	3.22%
Return on Capital Employed (ROCE)	1.30%	2.10%	7.90%	4.50%	3.60%	3.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.39%	3.65%	10.53%	5.11%	4.84%	3.86%
FCF Yield	3.93%	2.66%	-2.54%	-4.06%	-4.43%	3.83%
Dividend Yield	2.19%	3.46%	3.59%	3.08%	3.37%	3.33%
Payout Ratio	-	95.80%	33.18%	56.61%	63.84%	95.80%
Buyback Yield / Dilution	0.00%	0.00%	-0.10%	-0.15%	-0.00%	-0.01%
Total Shareholder Return	2.19%	3.47%	3.48%	2.93%	3.37%	3.32%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error